INTERPACE BIOSCIENCES, INC. Impairment of Intangible Assets, Finite-lived
INTERPACE BIOSCIENCES, INC. (IDXG) reported Impairment of Intangible Assets, Finite-lived of $3.96 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2024-04-01
- INTERPACE BIOSCIENCES, INC. impairment of intangible assets, finite-lived for fiscal 2022 was $3.96M.
- INTERPACE BIOSCIENCES, INC. impairment of intangible assets, finite-lived for fiscal 2020 was $12.00M.
- INTERPACE BIOSCIENCES, INC. impairment of intangible assets, finite-lived for fiscal 2016 was $3.40M.
- INTERPACE BIOSCIENCES, INC. impairment of intangible assets, finite-lived for fiscal 2015 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|
| 2022-12-31 | $3.96M 10-K · filed 2024-04-01 |
| 2020-12-31 | $12.00M 10-K · filed 2021-04-01 |
| 2016-12-31 | $3.40M 10-K · filed 2017-03-31 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-31 |
| 2012-12-31 | $4.40M 10-K · filed 2014-03-06 |